Publications

Journal Article Ppublish 1 citations
Electronic publication date
August 11, 2025

View on Pubmed.gov 39379676 | View on doi.org 10.1007/s10753-...

RNA-seq Based Transcriptome Analysis Reveals Role of Myoglobin in Rheumatoid Arthritis.

Search for publications in this journal Inflammation - 48(4):1745-1759

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease which manifests as joint destruction and bone erosion, could be caused by both genetic and environmental factors. Currently, the causes of RA are unknown, and targeted therapies are often associated with side effects and contraindications. The detection rate of RA in women is higher than men (3:1), however, there is still a lack of comprehensive understanding of the relationship between sex and RA. We hypothesized gender differences in RA prevalence and their associated mechanisms by performing genome-wide transcriptome analysis of synovial biopsy samples. The results indicated that myoglobin (MB) was differentially expressed between males and females, with higher expression in males than females in healthy populations, while the opposite was observed in RA patients. MB interacted with HLA class II histocompatibility antigen, DM beta (HLA-DMB) and the inflammatory factor interleukin 6 (IL-6) in the human synovial cell line MH7A.

References

Croia, C., R. Bursi, D. Sutera, F. Petrelli, A. Alunno, and I. Puxeddu. 2019. One year in review 2019: Pathogenesis of rheumatoid arthritis. Clinical and Experimental Rheumatology 37:347–357.

Smolen, J.S., J.C. Avila, and D. Aletaha. 2012. Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: Disassociation of the link between inflammation and destruction. Annals of the Rheumatic Diseases 71:687–693.

Aletaha, D., and J.S. Smolen. 2018. Diagnosis and management of rheumatoid arthritis: A review. JAMA 320:1360–1372.

Tieri, P., X. Zhou, L. Zhu, and C. Nardini. 2014. Multi-omic landscape of rheumatoid arthritis: Re-evaluation of drug adverse effects. Frontiers in Cell and Developmental Biology 2:59.

Conflict of interest statement

Declarations. Ethics Approval and Consent to Participate: This study involving human participants were reviewed and approved by the Ethics Committee of the Shaanxi Provincial People’s Hospital. The patients/participants provided their written informed consent to participate in this study. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.

MeSH

Specialties

Substances

Copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.